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Acute febrile abdomen represents a diagnostic challenge in patients with autosomal domi-
nant polycystic kidney disease (ADPKD). Although criteria have been proposed for cyst
infection (CyI) and hemorrhage (CyH), there is a lack of comparative assessments. Further-
more, distinguishing cystic from non-cystic complications remains problematic.
Design
ADPKD patients presenting with abdominal pain and/or fever between 01/2005 and 06/
2015 were retrospectively identified in a systematic computerized billing database. CyH
was defined as spontaneous intracystic density above 50 Hounsfield units on computed
tomography (CT). CyI was definite if confirmed by cyst puncture, and probable if 4 criteria
were met: 3-day fever, loin/liver tenderness, C-reactive protein (CRP) plasma levels
>50mg/L and no CT evidence for CyH. Other episodes were grouped as inflammation of
unknown origin (IUO).
Results
Among a cohort of 173 ADPKD patients, 101 presented with 205 episodes of abdominal
pain (n = 172) and/or fever (n = 33). 20 patients experienced 30 CyH, whereas 16 presented
23 episodes of definite (n = 11) or probable (n = 12) CyI. 35 IUO were observed in 31
patients. Clinically, fever was observed in 7% vs. 100% vs. 66% of CyH, CyI and IUO,
respectively. Biologically, CRP cut-off at 70 mg/dl showed 92% sensitivity and 81% specific-
ity in CyI diagnosis. Urine or blood cultures remained sterile in >90% of CyH, but were con-
tributive in 53.4% of CyI and IUO, with a 74.2% prevalence for E. coli. Radiologically,
ultrasounds, CT and magnetic resonance diagnosed CyI in 2.6%, 20% and 16.7% of cases,
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respectively. 18F-FDG positron-emission tomography (PET)/CT was done within a median
period of 7 days post antibiotics, and significantly changed patient management in 71.4%.
Conclusions
This retrospective single-center series underscores the usefulness of clinical–fever–and
biological–CRP–parameters, but emphasizes the limitations of bacteriological and radiolog-
ical investigations in cases of acute febrile abdomen in ADPKD patients. 18F-FDG-PET/CT
imaging may be helpful in such condition.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder
characterized by the development of cysts in the renal parenchyma irreversibly leading to
chronic kidney disease (CKD) [1,2]. ADPKD is the fourth most common cause for renal
replacement therapy [1]. Extra-renal manifestations, including hepatic cysts and connective
tissue abnormalities, are frequently observed in ADPKD patients [1,3,4].
Acute cyst complications, including cyst hemorrhage (CyH) and infection (CyI), represent
severe conditions of ADPKD. The incidence of CyI has been reported as 0.01 episode per
patient per year [5]. CyI has been associated with substantial risk for abscess formation and
life-threatening sepsis, which necessarily requires early and appropriate management [6]. The
diagnostic challenge of CyI may delay and/or cause erroneous patients’ management [7–9].
Furthermore, discriminating acute cyst complications from non-cystic abdominal diseases
is often difficult on the basis of unspecific clinical, biological and radiological parameters
[8,10,11]. Kidney and liver functions are usually unchanged at the time of CyH or CyI, and
blood or urine cultures most often remain sterile. Similarly, conventional imaging methods,
namely ultrasounds (US) and computed tomography (CT), show poor diagnostic yield in CyI,
even after administration of CT contrast agent [7,8,10].
Over the past decade, diagnostic criteria for CyH and CyI have been proposed [5,7,10,12–
14], as recently summarized by Lantinga M.A. and colleagues [8]. Typically, CyH is associated
with spontaneous intracystic density above 50 Hounsfield units on CT. CyI is “definite” when
confirmed by cyst content analysis showing neutrophils or bacteria. However, cyst puncture
may provoke rupture or contamination of adjacent cysts, and is therefore rarely performed.
Hence, CyI is regarded as “probable” when 4 criteria are concomitantly met: 3-day fever
>38°C, loin or liver tenderness, C-reactive protein (CRP) plasma levels>50mg/L, and no CT
evidence for CyH [5,10]. Additional clinical criteria, like weight loss or recent instrumentation
of urinary or biliary tract, and biological parameters, like hematuria or white blood cell (WBC)
count, have been listed, although their respective diagnostic yield remains unclear [8]. Isolated
reports suggest that diffusion sequences in magnetic resonance imaging (MRI) help improve
both sensitivity and specificity in CyI diagnosis[10,15]. Finally, 18-Fluoro-deoxy-glucose
(18FDG) positron-emission tomography (PET) has recently proven useful in infectious dis-
eases, including CyI [5,7,10,11,16–18].
In the present retrospective single-center series, we first characterized the monocentric inci-
dence of acute cyst complications in ADPKD patients over a 10-year period. Next, we investi-
gated the diagnostic yield of clinical, biological and imaging parameters in distinguishing CyI
from CyH and non-cystic conditions. Finally, we propose a diagnostic algorithm for the man-
agement of ADPKD patients presenting with acute febrile abdomen.
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Patients and Methods
Patients
This study was approved (#2016/108) by the Commission of Biomedical Ethics of the Univer-
sity of Liège Hospital (ULg CHU) in Liège, Belgium. Because of the retrospective design of the
study, no informed consent was given by the patients. Still, data were anonymised and de-iden-
tified prior access and analysis. Using the systematic computerized billing database of ULg
CHU, ADPKD patients presenting with abdominal pain and/or fever between January 2005
and June 2015 were retrospectively identified. The keywords were: “polycystic liver/congenital”
or “polycystic kidney, autosomal dominant” for all adult patients admitted to ULg Academic
Hospital (ULg CHU), including the emergency room. This search retrieved 234 patients. Next,
all medical files were systematically reviewed to exclude patients in whom conventional criteria
for ADPKD diagnosis proposed by Pei et al. were not met [19]. This systematic approach led to
the exclusion of 61 patients.
Diagnostic criteria for cyst complications
The diagnosis of CyH and CyI were based on the criteria proposed by Sallée M. and colleagues
[5]. Inflammation of unknown origin (IUO) included all episodes in which diagnostic criteria
for CyH or CyI were not met, in the absence of evidence for a non-cystic disease.
Imaging criteria for cyst infection
US, CT and MRI were considered as positive for CyI when enhanced wall thickening and
inflammatory infiltrates were detected in at least one cyst. More particularly, diagnostic MRI
criteria also included significant diminishment in diffusion on diffusion-weighted sequences.
18FDG-PET/CT was considered as positive for CyI when 18FDG uptake was increased around
at least one cyst[17].
Statistics
Continuous variables were checked for normality using the Kolmogorov-Smirnov test, and
homogeneity of variance was assessed using the Bartlett’s test. Non-parametric approach was
used when data did not satisfy the tests assumptions. Means were compared between groups
using Student t test or one way ANOVA with F test. MannWithney U test or Kruskal Wallis
teste were used otherwise. Categorical values are reported as number and percentages, and
compared with chi square test or Fisher exact test. A p-value below 0.05 was considered as sig-
nificant. Analyses were performed using Graphpad Prism 5.0.
Results
Cohort of patients with ADPKD presenting with suspected acute cyst
complication
We identified 173 patients with ADPKD who were admitted between 2005 and 2015 (Fig 1).
Among these, 101 patients (58.4%) presented with 205 events of acute abdominal pain
(n = 172) and/or fever (n = 33). In 48 ADPKD patients, i.e. 117 events, diagnostic work-up
using urine and blood analysis, as well as US or CT, detected non-cystic diseases, including
colorectal (n = 27, with 7 diverticulitis and 7 Clostridium difficile colitis), urologic (n = 27, with
7 kidney stones and 6 prostatitis), upper gastrointestinal (n = 11), bronco-pulmonary (n = 11,
with 9 pneumonia), iatrogenic (n = 8, with 6 post-surgical complications), hepato-pancreatic
(n = 7) and viral diseases (n = 7, with 4 CMV infections), as well as peritonitis (n = 6), neoplasia
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(n = 2), and others (n = 11). Of note, bacteremia is a sign of infection, but does not provide the
exact origin of the infection. Similarly, urosepsis in ADPKD patients may originate from both
cystic and non-cystic infection. So, our series included ADPKD patients with suspected cyst
complication, including documented urosepsis (by positive urinoculture) with no clear diag-
nostic evidence for a renal or a non-renal origin.
In 53 ADPKD patients, 88 events of acute cyst complications were suspected (S1 File). One
given patient may present with different types of cyst complications (S2 File). This cohort
included 7 episodes occurring in patients under chronic dialysis and 39 episodes occuring in
Fig 1. Selection process of patients with autosomal dominant polycystic kidney disease (ADPKD) presenting with suspected acute cyst
complication.One given patient may present with different types of cyst complications
doi:10.1371/journal.pone.0161277.g001
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kidney transplant recipients (KTR). Twenty patients showed a total of 30 episodes of CyH, as
confirmed by CT, and 16 patients presented with 23 episodes of CyI (Fig 1). Among these, 7
and 4 cases were definite kidney or liver CyI, respectively, and 10 and 2 were probable kidney
or liver CyI, respectively. Thirty-five episodes of suspected cyst complications in 31 patients
were categorized as IUO (Fig 1). As a whole, CyH and CyI in patients with ADPKD repre-
sented 25.8% of hospital admissions for abdominal pain and/or fever. Of important note, no
death could be directly attributed to CyH or CyI.
Clinical and biological parameters
Table 1 summarizes pertinent parameters observed in 88 episodes of suspected acute cyst com-
plication. Cases of definite CyI included 6 surgical procedures of nephrectomy (n = 5) or partial
hepatectomy (n = 1), and 5 percutaneous cyst punctures. Bacteriological identification in cyst
fluid was successful in 3 cases (27.3%), whereas 8 episodes showed neutrophils in cyst lumen.
Clinically, abdominal pain was found in nearly all patients with CyH or definite CyI. Fever was
observed in all patients with definite CyI, but was virtually absent in patients with CyH (n = 2/
30). Biologically, no significant difference was found between renal CyH (22.2%) versus renal
CyI (35.3%) regarding hematuria (Table 1). By contrast, leucocyturia was detected significantly
more frequently in renal CyI than renal CyH (41.1% vs. 11.1%, p<0.05). Groups of CyH and def-
inite CyI showed significant differences in CRP values at hospital admission (13.3±14.2 vs.
187.3±95.7, p<0.001) and at peak within the first 48h post admission (35.2±58.9 vs. 229.1±105.1,
p<0.001). The area under the receiver operating characteristic (ROC) curve (AUC) for CRP lev-
els in CyI diagnosis reached 0.91 for a cut-off set at 70 mg/dl, with a sensitivity of 92% and a
specificity of 81% (S1 Fig). By contrast, ANOVA showed similar levels of WBC count at the
admission (p, 0.20) and within the first 48h post admission (p, 0.14) in all groups of CyH, proba-
ble and definite CyI or IUO (Table 1).
Microbiological documentation
Among 88 episodes of suspected acute cyst complications in 53 ADPKD patients, a pathogen
bacterium was identified in 34 cases (38.6%), either in urine (n = 25, 28.4%), in blood (n = 19,
21.6%), or in both (n = 10, 11.4%) (Table 2). The most common organism was Escherichia coli
(70.6%), followed by K. pneumoniae (11.8%). Focusing on CyI, the causative bacterium was
found in 12 cases (52.2%), either in urine (n = 5, 21.7%), in blood (n = 9, 39.1%) or in both
(n = 2, 8.7%). E. coli represents the most frequent pathogen, with a prevalence of 91.7%. In
IUO, causative pathogens were identified in 19 cases (54.3%), either in urine (n = 17, 48.6%),
in blood (n = 8, 22.9%) or in both (n = 6, 17.1%). Expectedly, urine and blood cultures were
rarely positive (<10%) in CyH. Furthermore, contamination at the time of collection cannot
be excluded given the types of the organism, including Staphylococcus epidermidis or Strepto-
coccus agalactiae.
Conventional imaging techniques
Among 58 episodes of suspected cyst complications with no radiological evidence of CyH, 38
abdomen US were performed (67.9%), among which only 2 were suggestive of CyI. Likewise,
35 CT were performed (60.3%), including 13 after administration of contrast agent. CyI was
diagnosed in 7 cases (20%), among which 4 were performed using radiological agent. Finally, 6
MRI were performed (10.4%), with one contributive exam.
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18FDG-PET/CT imaging
18FDG-PET/CT was performed in 28 cases (31.8%) of suspected cyst complication (Fig 2)
within a median period of 11 days [3d; 28d] following admission and a median period of 7 days
[0d; 30d] following the initiation of antibiotics. Of note, 18FDG-PET/CT imaging in our series
was particularly used in ADPKD KTR (20/28, 71.4%). Among 11 definite CyI, 4 18FDG-PET/
CT were performed and confirmed the diagnosis in all cases (Table 1).
Among 12 probable CyI, 18FDG-PET/CT confirmed the diagnosis in 4/6 cases. The first
patient with probable CyI and negative 18FDG-PET/CT was a 66-year-old female KTR who had
been admitted for fever, myalgia and right hypochondrium pain for 15 days. She had previously
benefited from bilateral nephrectomy. Blood analysis showed CRP andWBC levels at 50.6 mg/L
and 4.250/mm3, respectively. Urinalysis did not detect hematuria or leucocyturia, and remained
sterile. CT was not contributive, nor was 18FDG-PET/CT performed 4 weeks post admission.
No antibiotic therapy was initiated, and the patient spontaneously recovered. The second
patient with probable CyI and negative 18FDG-PET/CT was a 65-year-old woman who pre-
sented with fever and right flank pain for 3 days. Blood analysis revealed CRP andWBC levels
at 463.2 mg/L and 12.240/mm3, respectively. Urinalysis detected hematuria without leucocy-
turia. Urine and blood cultures remained sterile. CT was not contributive. Still, i.v. antibiotic
therapy was administered for 14 days, with a sharp and significant recovery. 18FDG-PET/CT
was performed 6 days after antibiotherapy ended. Follow-up was unremarkable.
Finally, 18FDG-PET/CT was performed in 17 IUO, with 2 of them (11.7%) highlighting
renal CyI. The first case was a 64-year-old female KTR admitted for isolated inflammatory syn-
drome detected 15 days following kidney transplantation. Blood analysis showed CRP and
WBC levels at 214 mg/L and 13.400/mm3, respectively. Urinalysis detected leucocyturia
Table 2. Bacteriological documentation.
n Pathogen
ID (%)
Blood (+, %) Blood Strains Urine (+, %) Urine Strains






E. coli (n = 1)
Renal cyst
infection
Deﬁnite 7 60 57 E. coli (n = 2) 15 E. coli (n = 1)
S. epidermidis
(n = 1)
S. capitis (n = 1)
Probable 10 50 20 E. coli (n = 2) 40 E. coli (n = 4)
Liver cyst
infection
Deﬁnite 4 50 50 E. coli (n = 2) 0
Probable 2 50 50 Ecoli (n = 1) 0







S. aureus (n = 1)
S. aureus (n = 1) E. faecalis (n = 1)
C. koseri (n = 1)
P.mirabilis (n = 1)
doi:10.1371/journal.pone.0161277.t002
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without hematuria. Urine and blood cultures remained sterile. US of native and transplanted
kidneys was not contributive. Still, ciprofloxacine therapy was initiated. 18FDG-PET/CT was
performed 1 week post treatment initiation, and showed renal CyI. Antibiotics were maintained
for 6 weeks, and the evolution was favorable. The second case was a 46-year-old male KTR
who presented with fever, dysuria and pollakiuria for 2 days. His general practitioner immedi-
ately started cefuroxime. Blood analysis at admission revealed CRP and WBC levels at 250 mg/
L and 12.470/mm3, respectively. Urine and blood cultures remained sterile. Abdominal US was
not contributive. 18FDG-PET/CT was performed at day 13 after cefuroxime initiation, which
was subsequently shifted to ciprofloxacin for 6 weeks given PET/CT results suggestive of CyI.
In addition to these 2 CyI, 5 non-cystic inflammatory diseases were identified by 18FDG-PET/
CT among IUO, including prostatitis, graft pyelonephritis, ovarian cancer and pneumonia
(n = 2) (Fig 2). Of note, 1 18FDG-PET/CT was performed among 30 episodes of CyH (3.3%),
and did not show any increase in renal 18F-FDG uptake.
In sum, among 27 18FDG-PET/CT performed in 58 events of suspected cyst complications
excluding CyH, 10 (37%) led to the diagnosis of renal (n = 8) or hepatic (n = 2) CyI, 5 (18.5%)
Fig 2. Distribution of 18FDG-PET/CT imaging in patients with autosomal dominant polycystic kidney disease (ADPKD)
presenting with suspected cyst complication. The final diagnosis is provided on the basis of the entire work-up.
doi:10.1371/journal.pone.0161277.g002
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showed non-cystic diseases and 12 (44.4%) were not contributive (Table 3). Among these 12
negative 18FDG-PET/CT, 4 were done in ADPKD patients who spontaneously recover, which
reasonably excludes CyI. By contrast, the remaining 8 negative 18FDG-PET/CT were done
following a median period of 11 days [3d; 20d] of antibiotics. On the basis of 18FDG-PET/CT
negative results, the duration of antibiotic therapy was reduced in 5/8 cases (62.5%) to a
median period of 18 days [14d; 21d]. As a whole, the management of the patient was signifi-
cantly changed by 18FDG-PET/CT results in 20 cases (71.4%). More specifically, negative
18FDG-PET/CT (n = 13) lead to significant modifications of therapeutics in 7 cases (53.8%).
Positive 18FDG-PET/CT detecting a non-cystic inflammation changed patient management in
all cases (n = 5, 100%). Positive 18FDG-PET/CT detecting cyst infection (n = 10) significantly
modified therapeutics, including the duration of antibiotics, in 8 cases (80%).
Discussion
Acute cyst complications, including CyH and CyI, are common manifestations of ADPKD. At
Liège Academic Hospital (ULg CHU), CyH and CyI represent 25.8% of hospital admissions for
abdominal pain and/or fever in ADPKD patients. There is an established association between
renal cyst complications and the slope of CKD progression [20]. Hence, an urologic event
before the age of 35 has been recently proven as an independent risk factor for CKD progres-
sion[21–23]. In case of suspected cyst complication in ADPKD patients, the main diagnostic
steps include (i) to rule out non-cystic pathologies, (ii) to discriminate CyI from CyH, and (iii)
to exclude concurrent conditions, such as urinary or biliary tract obstruction[10]. Treatment of
CyI ideally requires localizing pyocysts and identifying causative organisms. Even though such
a sequence appears obvious, the real-life management of cyst complication is complex because
of the lack of specific symptoms, signs and imageries distinguishing cystic from non-cystic dis-
eases [10]. Consequently, patients may be exposed to delayed or erroneous treatment. Indeed,
while CyH treatment most often relies on painkillers and expectant management, CyI requires
an early and prolonged antibiotherapy, with inherent exposure to side-effects and cost [11,24].
Furthermore, liver pyocyst should be drained in case of resistance to well-conducted anti-
biotherapy and/or rapid relapse[25,26]. Mortality is mostly linked to liver CyI [13,25].
Table 3. Clinical and biological characteristics of the cohort upon 18FDG PET/CT use.
n Age Gender Dialysis KTR eGFR WBC CRP Germ ID
Urine Blood
(years) (male, %) (%) (%) (ml/min) (106/mm³) (mg/L) (+, %) (+, %)
18FDG PET/CT 28 56 ± 11 57 14 71 40 ± 17 10.2 ± 3.7 127 ± 125 28 28
cyst
infection
10 52 ± 11 70 20 50 36 ± 15 10.2 ± 2.4 207 ± 120 10 30
non-cystic
diseases
5 60 ± 10 60 0 100 40 ± 23 10.5 ± 2.6 38 ± 12 60 40
no 18FDG
uptake
13 56 ± 11 46 15 77 44 ± 17 10.1 ± 4.9 99 ± 121 31 23
No 18FDG
PET/CT
60 49 ± 15 50 5 31 67 ± 45 11.1 ± 4.7 89 ± 125 28 18
excl. cyst
hemorrhage
31 53 ± 17 42 10 48 50 ± 38 12.4 ± 5.5 157 ± 141 45 29
KTR, kidney transplant recipients; eGFR, estimated glomerular ﬁltration rate; WBC, white blood cells at
admission; CRP, C-reactive protein level at admission; ID, identiﬁcation. Mean +/- Standard Deviation.
doi:10.1371/journal.pone.0161277.t003
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The design of the present study mimics “real-life” situations, including all APDKD patients
presenting with suspected cyst complication. Clinically, pain did not help discriminate CyI
from CyH, whereas fever was significantly more frequent in CyI than CyH. Biologically, CRP
levels were significantly higher in CyI than CyH. Hence, the AUC for CRP levels in CyI diagno-
sis reached 0.91 for a cut-off set at 70 mg/dl, with a sensitivity of 92% and a specificity of 81%.
No difference was observed among groups concerning WBC counts. In urinalysis, hematuria
was observed in both renal CyI and CyH, whereas leucocyturia was mostly found in renal CyI.
In line with previous observations, pathogens were identified only in ~50% of CyI. Such an
information is essential for tailoring antibiotics, but does not reliably distinguish cystic from
non-cystic infections[8,10]. Radiologically, abdomen US, CT and MRI diagnosed CyI in 2.6%,
20% and 16.7% of cases, respectively. Abdomen US was performed in 47% of ADPKD patients
with CyI, with a positive yield of 9%. Such a low sensitivity questions its clinical usefulness in
assessing an ADPKD patient with suspected cyst complication. Ninety-one % of CyI under-
went CT. The main limitation of CT in ADPKD patients with CKD is the contra-indication for
i.v. contrast medium. In our series, 57% of CT were performed with contrast agent. Only 33%
and 22% of CT with or without contrast infusion disclosed CyI. Such limited gain observed
after administration of contrast material should be individually gauged on the basis of patient’s
baseline renal function. Conversely, CT imaging was useful to rule out non-cystic diseases in
43 cases among 117 events (Fig 1) and CyH. Finally, abdomen MRI with (n = 2) or without
(n = 2) diffusion-weighed imaging was performed in 17% of CyI, with a contributive yield of
25%. Because of its cost, restricted availability and poor diagnostic yield, the role of MRI
remains unclear in the management of ADPKD patients with suspected cyst complication.
Accumulative evidence supports that 18FDG-PET/CT may help (i) diagnose CyI, (ii) dis-
criminate CyI from non-cystic disease and (iii) localize pyocysts, thereby facilitating the man-
agement[17,27–29]. Of note, CyH has not been reported thus far with pathological uptake of
18FDG, which further help distinguish CyI from CyH[11,17]. The advantages of 18FDG-PET/
CT are rapid imaging, high target-to-background ratio, direct co-registration with low-dose
CT, and the absence of toxicity[17,30,31]. Limitations include cost and availability. In addition,
18FDG uptake is not specific to infection[31,32]. In Bobot M. et al.[11], 18FDG-PET-CT
showed 77% sensitivity and 100% specificity for CyI diagnosis. In our series, 18FDG-PET/CT
was performed in 10/23 CyI, with a positive yield of 8/10. One plausible explanation for nega-
tive results is that the procedure was performed later than the average. The impact of antibiot-
ics on 18FDG-PET/CT results is debated. Bobot M. et al. recommend 18FDG-PET/CT within 7
days of antibiotics initiation in ADPKD patients with suspected CyI[11,27]. Lantinga M. and
colleagues propose that 18FDG-PET/CT might help monitor antibiotics efficiency, which
indirectly suggests that late imaging induces false negative results. By contrast, observations
of Piccoli G.B. and colleagues support that 18F-FDG accumulation around pyocysts remains
detectable up to 6 weeks post treatment[7].
On the basis of these observations, we propose an algorithm to help clinicians discriminate
CyI from CyH and non-cystic diseases in ADPKD patients presenting with suspected acute
cyst complication (Fig 3). This is grounded on the conventional management of any patient
with acute febrile abdominal complaint [33], and starts with 3 simultaneous conditions:
ADPKD, fever (>38°C for 3days) and abdominal pain. If such a constellation of 3 criteria is
not met, the management of patients may follow another algorithmic approach, which is out of
scope of the present study. The first steps rely on blood analyses, including CRP plasma levels,
and abdomen CT. The use of contrast agent should be restricted to ADPKD patients with pre-
served kidney function. CT will help categorize the patients into 3 groups: (i) CT-proven CyH,
(ii) CT-proven cystic or non-cystic disease, and (iii) non-contributive CT. Such crucial infor-
mation would significantly change the management of ADPKD patients with fever and
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Fig 3. Diagnostic algorithm to manage patients with autosomal dominant polycystic kidney disease (ADPKD)
presenting with suspected acute cyst complication. *, On the basis of the conventional management (including blood and
urine analyses and abdomen imaging) of any patient with febrile abdominal pain in emergency conditions (33).
doi:10.1371/journal.pone.0161277.g003
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abdominal pain. Next, threshold of CRP is set at 70 mg/L. CyH is most likely in case of low
CRP, as reported by us and others[5,7,8,10]. By contrast, CRP above 70 mg/L is highly sugges-
tive of CyI. Urinalysis-proven leucocyturia would further support the diagnosis of renal CyI.
Blood and urine cultures should be executed before treatment initiation to eventually tailor
antibiotic therapy. On the basis of these criteria initially proposed by Sallée M. and colleagues
[5], diagnosing CyH or probable CyI is achievable, thereby allowing early and appropriate
management. In order to (i) confirm CyI diagnosis, (ii) locate pyocysts and (iii) eventually
monitor therapeutic efficiency, 18FDG-PET/CT should be performed within 7 days post
antibiotics.
Several limitations of this study have to be acknowledged, including the retrospective mono-
centric design with a limited number of heterogeneous patients, including CKD stages, ESRD
under chronic hemodialysis and KTR. The decision to perform imaging procedures, including
US, CT, MRI and/or 18F-FDG-PET/CT, was at the discretion of physicians in charge in the
absence of pre-established criteria. Few cyst punctures were performed, which weakens the
diagnostic gold-standard. However, the “real-life” design encompassing all ADPKD patients
with abdominal pain and/or fever allowed us to compare clinical, biological and imaging
parameters in CyI versus CyH and non-cystic diseases, thereby proposing a diagnostic algo-
rithm. Prospective trials are needed to test the significance of this algorithm, as well as to better
delineate the timing of 18FDG-PET-CT in diagnosis (and follow-up) of ADPKD patients with
acute febrile abdomen.
Supporting Information
S1 Fig. Receiver operating characteristic (ROC) curve of CRP plasma levels for the diagno-
sis of cyst infection in 88 episodes of acute febrile abdomen in 53 patients with autosomal
dominant polycystic kidney disease (ADPKD). The area under the curve reaches 0.91 for a
cut-off set at 70 mg/L, with a sensitivity of 92% and a specificity of 81%.
(TIF)
S1 File. Clinical characteristics of 88 episodes of suspected acute cyst complication in 53
patients with autosomal dominant polycystic kidney disease (ADPKD).
(PDF)
S2 File. Detailed characteristics of the cohort including 53 patients with autosomal domi-
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